Results 131 to 140 of about 5,768 (162)

Outcomes of patients with newly diagnosed acute myeloid leukemia with FLT3-tyrosine kinase domain mutations: Prognostic implications of NPM1 co-mutation. [PDF]

Cancer
Arora S, Jen WY, Yilmaz M, Deshmukh I, Senapati J, Loghavi S, Issa GC, Short NJ, Kadia TM, DiNardo CD, Borthakur G, Jabbour J, Pemmaraju N, Andreeff M, Takahashi K, Bhalla K, Popat U, Shpall EJ, Oran B, Abbas HA, Garcia-Manero G, Ravandi F, Kantarjian H, Daver N.   +23 more
europepmc   +1 more source

Post-HCT maintenance therapy for AML: who, when, why, how long? [PDF]

Hematology Am Soc Hematol Educ Program
Levis M.
europepmc   +1 more source

Impact of Somatic Gene Mutations on Prognosis Prediction in De Novo AML: Unraveling Insights from a Systematic Review and Meta-Analysis. [PDF]

Cancers (Basel)
Elfatih A, Ahmed N, Srour L, Mohammed I, Villiers W, Al-Barazenji T, Mbarek H, El Akiki S, Jithesh PV, Muneer M, Fareed S, Mifsud B.   +11 more
europepmc   +1 more source

TKD: Türkiye’de 60 Yıllık Bir Mücadelenin Adı?

Türk Kütüphaneciliği, 2013
openaire   +2 more sources

Using genomics to refine pediatric AML risk stratification. [PDF]

Hematology Am Soc Hematol Educ Program
Pigazzi M, Meshinchi S, Locatelli F.
europepmc   +1 more source

TKD Genel Merkezi XIII. Dönem Hesap Raporu

Türk Kütüphaneciliği, 1988
openaire   +1 more source

A Modified FLT3 PCR Assay Using a TapeStation Readout. [PDF]

Genes (Basel)
Blake EA, Ramineni M, Oltvai ZN.
europepmc   +1 more source

Chidamide combined with decitabine, venetoclax, and low-dose cytarabine for relapsed/refractory acute myeloid leukemia: a single-center case series. [PDF]

Front Oncol
Li Q, Ji J, Wu Y.
europepmc   +1 more source

XII. KÜTÜPHANE HAFTASI MÜNASEBETİYLE TKD GENEL BAŞKANLIĞINA GÖNDERİLEN TELGRAFLAR

Türk Kütüphaneciliği, 1975
openaire   +2 more sources